Big drug firms eye potential $7.2B animal vaccine market
Companies like Eli Lilly and Co. unit Elanco are focused on developing vaccines as alternatives to antibiotics.
Health Care & Life Sciences
Articles
Cialis users sue Lilly, claiming drug has ties to skin cancer
Seven men who took Cialis pills to treat erectile dysfunction sued Indianapolis drugmaker Eli Lilly and Co. this week, claiming they later suffered from skin cancer that was related to the medicine.
Anthem says Cigna deal at risk without merger ruling by year-end
Anthem’s lawyer, Christopher Curran, told U.S. District Judge John Bates in Washington, D.C., on Thursday that Cigna’s top management is "no longer interested in being pursued."
AIT meltdown derails huge Marian gift
Five years after pledging an astounding $48 million to help Marian University build a medical school, an Indianapolis businessman has paid only about one-fifth of that amount.
Aetna’s Obamacare reversal latest blow to U.S. health law
Health care insurance giant Aetna Inc., facing more than $300 million in losses from Affordable Care Act health plans this year, may exit Obamacare markets.
CNO says assets hard to value at Platinum-linked insurer trusts
CNO Financial shares dropped 2.8 percent Monday morning after declining 5.5 percent last week. The Carmel-based insurer said last week that it was scrutinizing a risk-transfer arrangement with Beechwood Re, the reinsurer linked to embattled hedge fund Platinum Partners.
Anthem seeks big rate increase in Connecticut
Indianapolis-based Anthem Inc. has asked for an average 26.8 percent rate increase for individual plans offered on and off the state's health insurance exchange.
Indiana continues to lead U.S. in pharmacy robberies
There were more pharmacy robberies in Indiana last year than California, which has a population about six times larger.
Incoming Lilly CEO pick to focus globally
Dave Ricks will begin guiding the company during a period of relative calm compared with the trying times John Lechleiter navigated during his eight years at the helm.
‘Smooth transition’ predicted as Lilly turns to experienced exec
Over the last eight years, Eli Lilly relied on a three-decade company veteran to steer it through declining sales and a struggling product pipeline. Now, it’ll rely on another long-time executive for its next chapter.
Anthem prepping for hardball fight with feds over Cigna deal
The Indianapolis-based health insurer said its participation in the government’s health insurance exchanges—a sore subject for the Obama administration that is trying to stop the acquisition—may be at stake.
With financial house in order, CNO branches into investments
The insurer started two new businesses that extend its reach into the investment world, paving the way for its salespeople to sell insurance, securities and advice.
CNO tightens oversight on deal with reinsurer linked to Platinum
CNO Financial Group Inc. said it’s scrutinizing a risk-transfer arrangement with Beechwood Re, the reinsurer linked to embattled hedge fund Platinum Partners.
Anthem’s medical spending rises on higher Obamacare costs
Anthem Inc. shares fell Wednesday after the Indianapolis-based insurer said it expects to lose money on Affordable Care Act plans this year. The company had been planning to break even.
Lilly CEO Lechleiter to retire at end of year
John Lechleiter has been the company’s CEO since 2008. The announcement Wednesday morning of his retirement comes one day after the firm announced strong revenue and profit for its second quarter, indicating that Lechleiter’s initiatives have paid off.
CNO reports higher profit, tops analyst expectations
Carmel-based CNO Financial Group Inc. on Tuesday reported quarterly earnings that slightly exceeded analyst predictions.
Lilly beats analyst expectations, lays out bright outlook for rest of decade
CEO John Lechleiter said the company's strong R&D pipeline has put it on track to report average annual revenue growth of at least 5 percent through the remainder of the decade.
IU Health opens urgent care center in Plainfield
The health system has opened five urgent care facilities in the area since the beginning of last year.
Analysts expect Anthem-Cigna deal to unravel after Fed lawsuit
Cigna doesn’t appear like it’s ready to put up a fight to keep alive its $48 billion deal with Anthem, analysts say. But Aetna and Humana seem poised to put up more of a battle over their proposed merger.
Insurance commissioner says she has no conflict in merger
Connecticut Insurance Commissioner Katharine Wade contends she has no conflict of interest that would prevent her from overseeing a proposed merger between Indianapolis-based Anthem Inc. and Bloomfield, Connecticut-based Cigna Corp.